Metabolon to Work With InnVentis to Study Chronic Inflammatory Diseases
05. Januar 2017 10:05 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced today that it has entered into an agreement with InnVentis Ltd. to apply...
Metabolon Raises Additional $15 Million in Funding From Essex Woodlands
05. Dezember 2016 10:52 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced today that it has raised an additional $15 million in funding from...
Metabolon Launches Meta IMD™ Test to Speed Diagnosis of Inherited Metabolic Disorders
28. September 2016 10:05 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 28, 2016 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced today that Meta IMD™ is now available to physicians as a CLIA...
Metabolon Closes $15 Million Financing to Support Precision Medicine Growth Opportunities
11. August 2016 10:10 ET
|
Metabolon, Inc.
Financing Adds Essex Woodlands as New Investor Scott Barry to Join Metabolon’s Board of Directors RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global...
Metabolon to Develop accuGFR™ Kidney Function Test With Johns Hopkins and Tufts Medical Center
02. Juni 2016 16:00 ET
|
Metabolon, Inc.
More accurate kidney function test needed for chronic kidney disease“Silent killer” can go undetected without symptoms until patient has lost 90 percent of kidney function RESEARCH TRIANGLE PARK,...
Metabolon Identifies Biomarkers with Superior Diagnostic Performance Over Creatinine for Chronic Kidney Disease
28. April 2016 15:50 ET
|
Metabolon, Inc.
Data presented at National Kidney Foundation 2016 Spring Clinical MeetingsMetabolites form basis of accuGFR™ test in development RESEARCH TRIANGLE PARK, N.C., April 28, 2016 (GLOBE NEWSWIRE) --...
Metabolon and SYNLAB Group Form Commercialization Collaboration for Quantose™ IR Diagnostic
29. März 2016 09:59 ET
|
Metabolon, Inc.
SYNLAB Group to market Quantose IR, a laboratory-developed test used to identify insulin resistanceInitial launch in SpainAdditional markets to follow in 2016 RESEARCH TRIANGLE PARK, N.C., March 29,...
Lisa Miller Joins Metabolon as VP of Precision Medicine
07. Dezember 2015 16:15 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announces that Lisa A. Miller has been appointed Vice President and General...
Metabolon and Baylor College of Medicine Show Metabolomics May Play Key Role in Precision Medicine
17. August 2015 17:34 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 17, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, today announced study results indicating that its technology is emerging as an...
Darin Leigh Joins Metabolon as Chief Commercial Officer
06. Juli 2015 11:18 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., July 6, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announces that Darin Leigh has been appointed Chief Commercial Officer, a new...